Quantcast

Latest Crohn's disease Stories

2014-05-21 23:08:04

ReportsnReports.com adds “Crohn’s Disease Drug Market and Pipeline Analysis” report to its research store. Dallas, Texas (PRWEB) May 21, 2014 Under the umbrella of inflammatory bowel diseases, Crohn’s disease and ulcerative colitis are two most common disorders. Though both these disorders have similar symptoms, the difference arises in the areas affected in the gastrointestinal tract (GI tract). The Crohn’s disease in most cases affects the end of the small bowel (the ileum)...

2014-05-20 20:22:08

DEERFIELD, Ill. and OSAKA, Japan, May 20, 2014 /PRNewswire/ -- Takeda Pharmaceutical Company Limited ("Takeda") and its wholly-owned subsidiary, Takeda Pharmaceuticals U.S.A., Inc., today announced that the United States (U.S.) Food and Drug Administration (FDA) simultaneously approved a new biologic therapy, Entyvio((TM)) (vedolizumab), for the treatment of adults with moderately to severely active ulcerative colitis (UC) and Crohn's disease (CD). ( ) "Entyvio is a new option that...

2014-05-19 12:31:13

LONDON, May 19, 2014 /PRNewswire/ -- Reportbuyer.com has added a new market research report:Gastrointestinal Therapeutics in Asia-Pacific Markets to 2019 - Strong Potential for Pipeline Biologics on Account of High Regional Unmet Needhttp://www.reportbuyer.com/pharma_healthcare/treatments/gastrointestinal_therapeutics_asia_pacific_markets_2019_strong_potential_pipeline_biologics_account_high_regional_unmet_need.htmlGastrointestinal Therapeutics in Asia-Pacific Markets to 2019 - Strong...

2014-05-15 16:27:54

NEW YORK, May, 15, 2014 /PRNewswire-USNewswire/ -- In an effort to increase their long-standing commitment of improving the lives of those with inflammatory bowel disease (IBD), the Crohn's & Colitis Foundation of America (CCFA) will host the first U.S. IBD2020 meeting from May 16(th)- May 18(th) in New Orleans, LA. http://photos.prnewswire.com/prnvar/20140515/88144 "IBD2020 USA is a critical meeting of some of the brightest minds who are thinking about both IBD and Quality of...

2014-05-14 08:28:16

LONDON, May 14, 2014 /PRNewswire/ -- Reportbuyer.com has added a new market research report:PharmaPoint: Crohn's Disease - 5EU Drug Forecast and Market Analysis to 2022http://www.reportbuyer.com/pharma_healthcare/therapeutic/pharmapoint_crohns_disease_5eu_drug_forecast_market_analysis_2022.htmlPharmaPoint: Crohn's Disease - 5EU Drug Forecast and Market Analysis to 2022SummaryThe Crohn's disease (CD) market is currently very dynamic, with novel biologic therapies on the...

2014-05-08 09:51:38

Old data can be mined to find new genetic associations and gene interactions The power of genome-wide association studies (GWAS) to detect genetic influences on human disease can be substantially increased using a statistical testing framework reported in the May issue of the journal GENETICS. Despite the proliferation of GWAS, the associations found so far have largely failed to account for the known effects of genes on complex disease — the problem of "missing heritability."...

2014-05-05 20:24:20

LONDON, May 5, 2014 /PRNewswire/ -- Reportbuyer.com has added a new market research report:Gastrointestinal Therapeutics in Major Developed Markets to 2019 - New Drug Approvals and Promising Pipeline to Counter Declines from Patent Expirieshttp://www.reportbuyer.com/pharma_healthcare/treatments/gastrointestinal_therapeutics_major_developed_markets_2019_new_drug_approvals_promising_pipeline_counter_declines_patent_expiries.htmlGastrointestinal Therapeutics in Major Developed Markets to...

2014-05-05 08:30:08

- The long-term safety profile was consistent with pivotal trials of Cimzia® ATLANTA, May 5, 2014 /PRNewswire/ -- UCB announced today results from the PRECiSE 3 7-year open label extension clinical trial of Cimzia(®) (certolizumab pegol), the longest continuous trial of an anti-TNF therapy evaluating long-term safety in Crohn's disease. Remission was also assessed over the trial period. Results were presented at Digestive Disease Week (DDW), taking place in Chicago from May 3-6. "The...

2014-05-05 08:29:18

ENDOCAPSULE 10 Delivers Outstanding Visualization, Improved Efficiency and Enhanced Features for Noninvasive Observation of the Small Intestine CENTER VALLEY, Pa., May 5, 2014 /PRNewswire/ -- Olympus, a precision technology leader in designing and delivering innovative solutions in Medical and Surgical Products, among other core businesses, announced today the commercial availability of its 510(k) cleared, next-generation ENDOCAPSULE 10 System for small bowel capsule endoscopy...

2014-05-05 08:28:29

Academic and Industry Teams Converge to Focus on Inflammatory Bowel Disease and Advance Innovative Interception and Prevention Strategies SPRING HOUSE, Pa., May 5, 2014 /PRNewswire/ -- Janssen Research & Development, LLC (Janssen) announced today the establishment of a Cooperative Research and Development Agreement (CRADA) with the Naval Medical Research Center (NMRC), Prometheus Laboratories Inc. (Prometheus), Mayo Clinic, Rochester, Minnesota (Mayo Clinic), Centre Hospitalier Regional...


Word of the Day
jument
  • A beast of burden; also, a beast in general.
'Jument' ultimately comes from the Latin 'jugum,' yoke.
Related